Hide Board Information

Show Board Information

Intel Corporation INTC

Board Mod: Add me as mod

Asst Mods:

Last Post: 04/13/2024 8:05:58 AM

Board Marks: 28

Posts Today: 0

Board Views Today: 17

Intel Corporation (NASDAQ: INTC) Stock Message Board

1. INTC Company Profile

    

2. INTC Time & Sales

    

3. INTC Recent News

    

4. INTC Filings

    

5. INTC Financials

    

6. INTC Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

9	INTC Stock Charts Last: UNCH Saturday, March 1,	chartguy89	03/01/2014 6:39:16 PM
8	INTC Stock Charts Last: -0.04 Thursday, February	chartguy89	02/27/2014 11:28:34 PM
7	INTC Stock Charts Last: +0.21 Monday, February	chartguy89	02/24/2014 4:45:30 PM
6	INTC Stock Charts Sunday, February 23, 2014 at	chartguy89	02/23/2014 8:31:01 PM
5	INTC Stock Chart 24.205 Monday, February 10, 2014	chartguy89	02/10/2014 8:25:11 AM
4	Media Alert: Intel to Showcase Ultrabook	Bible Feed	11/28/2012 6:59:02 AM
3	Chip Shot: Intel Provides Software Developers	Bible Feed	11/28/2012 6:58:12 AM
2	Chip Shot: Intel EPSD Rolls out Intel Xeon	Bible Feed	11/28/2012 6:57:02 AM
1	Intel Earnings Preview: Negligible to Slow	Bible Feed	07/12/2012 2:41:56 AM

Newer

Recent Articles

• Microsoft's Strategic Shift in AI Development and Ethics
• U.S.-China Trade Agreement: Impact on Economy and Relations
• Recent Trends in Large Cap Stocks: Key Market Movers
• Avidity Biosciences Announces Acquisition by Novartis AG Deal
• Legal Action Encouraged for Designer Brands Inc. Investors
• Exploring the Future of Kratom: Insights from Kratom Bird
• Novartis Enhances Neuroscience Pipeline Through Avidity Biosciences Acquisition
• EggNest™ System: A Breakthrough in Radiation Safety for Cath Labs
• Critical Importance of Court Reporting in High-Profile Trials
• Mark Cuban's Insight: Billionaires and Market Stability
• Blockchain Jungle 2025: Experience Innovation in Technology
• Fortinet Shareholders Urged to Join Securities Class Action
• Controversial $130 Million Donation to Pentagon Raises Concerns
• Fate Therapeutics: Advances in CAR T-Cell Therapy for Lupus
• JPMorgan Faces Legal Challenge Over Excessive Fraud Fees
• JPMorgan Fights $115 Million Legal Fees After Fraud Case
• Fate Therapeutics Unveils Promising Data on FT819 CAR T-Cell Therapy
• Baxter International, Inc. Faces Class Action Lawsuit Amid Losses
• ETC Mining Unveils Mobile App for Cloud Mining of XRP, BTC, ETH
• Top 5 Stocks Gaining Investor Interest for Future Growth
• Dow Inc. Class Action Lawsuit: Opportunities for Investors
• WPP Investors Urged to Participate in Securities Class Action
• Credit Blockchain Revolutionizes AI Integration in Crypto
• Semler Investors Face Class Action Deadline - Act Now!
• Urgent Alert for Dow Inc. Investors: Class Action Timeline Approaches
• Trump's Bold Strategy: A Revolutionary Shift in Mining
• LifeMD's Class Action Lawsuit: What Investors Need to Know
• Tech Giants Face New Challenges Amid Rivalry and Innovation
• America's Strategic Shift: Mining the Future of Resources
• MSP Miner's Innovative Cloud Mining Platform for Universal Access
• Celebrating Musical Excellence: Heida Hermanns Competition Event
• Essential Steps for LifeMD Inc. Investors Before Deadline
• Investors Encouraged to Review Claims Related to Savara Inc
• Navigating Disagreements: Jeff Bezos' Unique Leadership Style
• Investors Alert: Semler Scientific Faces Legal Investigation
• Investigation on Baxter International: An Investor's Insight
• Legal Update for V.F. Corporation Investors on Shareholder Action
• Investigating Quantifiable Losses for Quanex Building Products
• Investigation Launched into Marex Group Investor Claims
• Important Class Action Update for Quanex Building Products
• Cytokinetics Investigation: Legal Options for Shareholders
• Investigation Launched on Behalf of LifeMD Shareholders
• Tronox Holdings: Investors Urged to Join Class Action Suit
• Investors of Molina Healthcare Urged to Consider Legal Options
• Upcoming Legal Action for Jasper Therapeutics Investors Explained
• Investigation Into aTyr Pharma: Shareholder Losses Explored
• KBR Shareholder Insights: Investigating Investor Claims
• MoonLake Immunotherapeutics Shareholder Updates: Key Insights
• Investigating the Recent Decline of Tvardi Therapeutics Stock
• Investors Mobilize for WPP Class Action Amid Concerns